References
Aghagoli, G, Gallo Marin, B, Soliman, LB, Sellke, FW. (2020). Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review. J Card Surg . doi:10.1111/jocs.14538
Boettler, T, Newsome, PN, Mondelli, MU, Maticic, M, Cordero, E, Cornberg, M, Berg, T. (2020). Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. JHEP Rep . 2(3), 100113. doi:10.1016/j.jhepr.2020.100113
Chen, R, Liang, W, Jiang, M, Guan, W, Zhan, C, Wang, T, . . . Medical Treatment Expert Group for, C. (2020). Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China. Chest . doi:10.1016/j.chest.2020.04.010
Cheng, Y, Luo, R, Wang, K, Zhang, M, Wang, Z, Dong, L, . . . Xu, G. (2020). Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int . 97(5), 829-838. doi:10.1016/j.kint.2020.03.005
Cook, TM. (2020). The importance of hypertension as a risk factor for severe illness and mortality in COVID-19. Anaesthesia . 75(7), 976-977. doi:10.1111/anae.15103
Ji, HL, Zhao, R, Matalon, S, Matthay, MA. (2020). Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility. Physiol Rev . 100(3), 1065-1075. doi:10.1152/physrev.00013.2020
Jordan, RE, Adab, P, Cheng, KK. (2020). Covid-19: risk factors for severe disease and death. BMJ . 368, m1198. doi:10.1136/bmj.m1198
Klonoff, DC, Umpierrez, GE. (2020). Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity.Metabolism . 108, 154224. doi:10.1016/j.metabol.2020.154224
Lai, CC, Shih, TP, Ko, WC, Tang, HJ, Hsueh, PR. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents . 55(3), 105924. doi:10.1016/j.ijantimicag.2020.105924
Lei, F, Liu, YM, Zhou, F, Qin, JJ, Zhang, P, Zhu, L, . . . Yuan, Y. (2020). Longitudinal association between markers of liver injury and mortality in COVID-19 in China. Hepatology . doi:10.1002/hep.31301
Leung, C. (2020). Risk factors for predicting mortality in elderly patients with COVID-19: A review of clinical data in China. Mech Ageing Dev . 188, 111255. doi:10.1016/j.mad.2020.111255
Li, L, Zhang, B, He, B, Gong, Z, Chen, X. (2020). Critical patients with coronavirus disease 2019: Risk factors and outcome nomogram. J Infect . 80(6), e37-e38. doi:10.1016/j.jinf.2020.03.025
Li, T, Zhang, Y, Gong, C, Wang, J, Liu, B, Shi, L, Duan, J. (2020). Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China. Eur J Clin Nutr . doi:10.1038/s41430-020-0642-3
Li, X, Xu, S, Yu, M, Wang, K, Tao, Y, Zhou, Y, . . . Zhao, J. (2020). Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol . doi:10.1016/j.jaci.2020.04.006
Lin, A, He, ZB, Zhang, S, Zhang, JG, Zhang, X, Yan, WH. (2020). Early risk factors for the duration of SARS-CoV-2 viral positivity in COVID-19 patients. Clin Infect Dis . doi:10.1093/cid/ciaa490
Lippi, G, Plebani, M. (2020). Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. Clin Chim Acta . 505, 190-191. doi:10.1016/j.cca.2020.03.004
Liu, W, Tao, ZW, Wang, L, Yuan, ML, Liu, K, Zhou, L, . . . Hu, Y. (2020). Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl) . 133(9), 1032-1038. doi:10.1097/CM9.0000000000000775
Liu, X, Zhou, H, Zhou, Y, Wu, X, Zhao, Y, Lu, Y, . . . Wang, Y. (2020). Risk factors associated with disease severity and length of hospital stay in COVID-19 patients. J Infect . doi:10.1016/j.jinf.2020.04.008
Long, L, Zeng, X, Zhang, X, Xiao, W, Guo, E, Zhan, W, . . . Lai, K. (2020). Short-term outcomes of COVID-19 and risk factors for progression. Eur Respir J . 55(5). doi:10.1183/13993003.00990-2020
Mehra, MR, Desai, SS, Kuy, S, Henry, TD, Patel, AN. (2020). Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med . doi:10.1056/NEJMoa2007621
Pan, C, Wen, A, Li, X, Li, D, Zhang, Y, Liao, Y, . . . Shen, S. (2020). Development and Validation of a Risk Prediction Model of Vancomycin-Associated Nephrotoxicity in Elderly Patients: A Pilot Study.Clin Transl Sci . 13(3), 491-497. doi:10.1111/cts.12731
Wang, D, Hu, B, Hu, C, Zhu, F, Liu, X, Zhang, J, . . . Peng, Z. (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA . doi:10.1001/jama.2020.1585
Wang, D, Yin, Y, Hu, C, Liu, X, Zhang, X, Zhou, S, . . . Peng, Z. (2020). Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China. Crit Care . 24(1), 188. doi:10.1186/s13054-020-02895-6
Wei, YY, Wang, RR, Zhang, DW, Tu, YH, Chen, CS, Ji, S, . . . Fei, GH. (2020). Risk factors for severe COVID-19: Evidence from 167 hospitalized patients in Anhui, China. J Infect . doi:10.1016/j.jinf.2020.04.010
Yang, J, Zheng, Y, Gou, X, Pu, K, Chen, Z, Guo, Q, . . . Zhou, Y. (2020). Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis . 94, 91-95. doi:10.1016/j.ijid.2020.03.017
Yao, Q, Wang, P, Wang, X, Qie, G, Meng, M, Tong, X, . . . Chu, Y. (2020). A retrospective study of risk factors for severe acute respiratory syndrome coronavirus 2 infections in hospitalized adult patients. Pol Arch Intern Med . 130(5), 390-399. doi:10.20452/pamw.15312
Yu, X, Sun, X, Cui, P, Pan, H, Lin, S, Han, R, . . . Fu, C. (2020). Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China. Transbound Emerg Dis . doi:10.1111/tbed.13604
Zhang, J, Wang, X, Jia, X, Li, J, Hu, K, Chen, G, . . . Dong, W. (2020). Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect . 26(6), 767-772. doi:10.1016/j.cmi.2020.04.012
Zheng, KI, Gao, F, Wang, XB, Sun, QF, Pan, KH, Wang, TY, . . . Zheng, MH. (2020). Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease. Metabolism . 108, 154244. doi:10.1016/j.metabol.2020.154244
Zheng, Z, Peng, F, Xu, B, Zhao, J, Liu, H, Peng, J, . . . Tang, W. (2020). Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect . doi:10.1016/j.jinf.2020.04.021
Zhou, F, Yu, T, Du, R, Fan, G, Liu, Y, Liu, Z, . . . Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet . 395(10229), 1054-1062. doi:10.1016/S0140-6736(20)30566-3
Zhou, Y, Zhang, Z, Tian, J, Xiong, S. (2020). Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus. Ann Palliat Med . 9(2), 428-436. doi:10.21037/apm.2020.03.26
Zhu, Z, Cai, T, Fan, L, Lou, K, Hua, X, Huang, Z, Gao, G. (2020). Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019. Int J Infect Dis . 95, 332-339. doi:10.1016/j.ijid.2020.04.041